Translational PET imaging research

Neurobiology of Disease
Richard Hargreaves, Eugenii A Rabiner

Abstract

The goal of any early central nervous system (CNS) drug development program is always to test the mechanism and not the molecule in order to support additional research investments in late phase clinical trials. Confirmation that drugs reach their targets using translational positron emission tomography (PET) imaging markers of engagement is central to successful clinical proof-of-concept testing and has become an important feature of most neuropsychiatric drug development programs. CNS PET imaging can also play an important role in the clinical investigation of the neuropharmacological basis of psychiatric disease and the optimization of drug therapy.

References

Dec 1, 1999·Biological Psychiatry·W C DrevetsC Mathis
Jul 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·Anissa Abi-DarghamMarc Laruelle
Jan 12, 2002·Nuclear Medicine and Biology·Dale O KiesewetterWilliam C Eckelman
Jul 3, 2003·Nature Reviews. Drug Discovery·Richard Frank, Richard Hargreaves
Aug 26, 2003·European Journal of Clinical Pharmacology·M BergstromB Langstrom
Nov 27, 2004·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Olof SolinH Donald Burns
Jan 13, 2006·Journal of Pharmacokinetics and Pharmacodynamics·M BergstromB Langstrom
Apr 11, 2006·Nature Reviews. Drug Discovery·David BorsookRichard Hargreaves
Jun 3, 2008·Seminars in Nuclear Medicine·Jeffrey H Meyer
Sep 3, 2008·Archives of General Psychiatry·Nicole Praschak-RiederJeffrey H Meyer
Jan 7, 2009·Archives of General Psychiatry·O D HowesPaul M Grasby
Feb 3, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Henricus G RuhéAart H Schene
Feb 14, 2009·Nature Reviews. Drug Discovery·Gerhard GründerArvid Carlsson
May 28, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Lisbeth MarnerGitte M Knudsen
Sep 24, 2009·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Jean-Dominique GallezotRichard E Carson
Dec 17, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Garth E TerryRobert B Innis
May 5, 2010·Archives of General Psychiatry·Julia SacherJeffrey H Meyer
Jun 18, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Sharon AshworthVincent J Cunningham
Aug 20, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Andrea Varrone, Christer Halldin
Sep 14, 2010·Experimental Neurology·Gunasingh MasilamoniYoland Smith
Oct 14, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Sergio AbanadesRoger N Gunn
Jun 16, 2011·Medicinal Research Reviews·Louise M PatersonGitte M Knudsen
Jul 19, 2011·Expert Opinion on Drug Discovery·David BorsookLino Becerra
Aug 16, 2011·British Journal of Clinical Pharmacology·Paul M MatthewsRoger N Gunn
Sep 1, 2011·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Paul ShotboltEugenii A Rabiner
Jan 26, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Roger N GunnMarc Laruelle
Mar 22, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Terry JonesPET Research Advisory Company

Citations

Apr 1, 2016·The Journal of Pharmacology and Experimental Therapeutics·Kazumi KogaShigeyuki Chaki
Jun 30, 2016·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Aarti Sawant-BasakTimothy McCarthy
Dec 6, 2016·Nature Chemical Biology·J Matthew DubachRalph Weissleder
May 2, 2017·ACS Chemical Neuroscience·Guy A Higgins
Apr 19, 2017·Chemistry : a European Journal·Carlotta TaddeiAntony D Gee
Jul 14, 2017·Chemistry : a European Journal·Hema S KrishnanSteven H Liang
Jul 23, 2019·Chemical Communications : Chem Comm·James E Kath, Aleksandra Baranczak
Sep 22, 2019·European Journal of Nuclear Medicine and Molecular Imaging·Stuart P McCluskeyO D Howes
Sep 10, 2020·Frontiers in Neuroscience·Jin Su KimMin-Hyun Park
Dec 26, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·João Franco MachadoJoão D G Correia
May 30, 2019·The AAPS Journal·Jean-Marie Nicolas, Elizabeth C M de Lange
Jul 10, 2019·Future Medicinal Chemistry·Hugues Prevet, Ian Collins
Mar 29, 2014·Chemical Society Reviews·Lin ZhuHank F Kung

Related Concepts

Diagnosis, Psychiatric
Central Nervous System Agents
Positron-Emission Tomography
Drug Prospecting
Knowledge Translation
Mental Disorders
Biological Markers
Clinical Trials
Pharmacotherapy
Research

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Drug Discovery Today
Robert A Comley, David Kallend
Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging
Chongzhao RanAnna Moore
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
Mizuho SekineTetsuya Suhara
© 2021 Meta ULC. All rights reserved